Get started
RELIEF THERAPEUTICS Holding AGRELIEF THERAPEUTICS Holding AGRELIEF THERAPEUTICS Holding AG

RELIEF THERAPEUTICS Holding AG

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsSeasonalsETFs

RLF chart


Full chart

Key stats


Market capitalization
‪42.16 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.359 CHF
Net income (FY)
‪−17.12 M‬ CHF
Revenue (FY)
‪8.42 M‬ CHF
Shares float
‪9.92 M‬
Beta (1Y)
0.03

Employees


Employees (FY)
31
Revenue / Employee (1Y)
‪271.52 K‬ CHF
Net income / Employee (1Y)
‪−552.23 K‬ CHF

About RELIEF THERAPEUTICS Holding AG


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
relieftherapeutics.com
Headquarters
Geneva
Founded
2013
ISIN
CH1251125998
FIGI
BBG006M6ZG95
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.

Check out other big names from the same industry as RLF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RLF news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RLF is 2.935 CHF — it has increased by 11.60% in the past 24 hours. Watch RELIEF THERAPEUTICS Holding AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange RELIEF THERAPEUTICS Holding AG stocks are traded under the ticker RLF.
RLF stock has risen by 11.60% compared to the previous week, the month change is a 11.60% rise, over the last year RELIEF THERAPEUTICS Holding AG has showed a −49.12% decrease.
RLF reached its all-time high on Nov 12, 2024 with the price of 7.454 CHF, and its all-time low was 2.098 CHF and was reached on May 12, 2025. View more price dynamics on RLF chart.
See other stocks reaching their highest and lowest prices.
RLF stock is 10.39% volatile and has beta coefficient of 0.03. Track RELIEF THERAPEUTICS Holding AG stock price on the chart and check out the list of the most volatile stocks — is RELIEF THERAPEUTICS Holding AG there?
Today RELIEF THERAPEUTICS Holding AG has the market capitalization of ‪42.16 M‬, it has increased by 0.34% over the last week.
Yes, you can track RELIEF THERAPEUTICS Holding AG financials in yearly and quarterly reports right on TradingView.
RLF net income for the last half-year is ‪−4.48 M‬ CHF, while the previous report showed ‪−12.56 M‬ CHF of net income which accounts for 64.35% change. Track more RELIEF THERAPEUTICS Holding AG financial stats to get the full picture.
No, RLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 1, 2025, the company has 31 employees. See our rating of the largest employees — is RELIEF THERAPEUTICS Holding AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RELIEF THERAPEUTICS Holding AG EBITDA is ‪−6.44 M‬ CHF, and current EBITDA margin is −60.69%. See more stats in RELIEF THERAPEUTICS Holding AG financial statements.
Like other stocks, RLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RELIEF THERAPEUTICS Holding AG stock right from TradingView charts — choose your broker and connect to your account.